Uncompetitive inhibition of [3H]1,3-di-o-tolyl-guanidine-defined σ binding sites by desipramine, propranolol and alprenolol in rat brain

European Journal of Pharmacology

Volumn 331, Issue 2-3, 1997, Pages 319-323

  Shirayama, Yukihiko ^a,c,d   Takahashi, Kiyohisa ^a,b   Nishikawa, Toru ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Kanto Teishin Hospital   (Japan)

Author keywords

Binding site; Alprenolol; Cerebral cortex; Desipramine; DTG (13 di o tolylguanidine); Propranolol; Rat

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 4 PHOSPHONOMETHYLPIPECOLIC ACID; ALPRENOLOL; CLOMIPRAMINE; DESIPRAMINE; DIZOCILPINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; PENTAZOCINE; PROPRANOLOL; RISPERIDONE; SIGMA OPIATE RECEPTOR; 1,3 DITOLYLGUANIDINE; 1,3-DITOLYLGUANIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GUANIDINE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; HIPPOCAMPUS; KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG ANTAGONISM; METABOLISM; WISTAR RAT;

ADRENERGIC BETA-ANTAGONISTS; ALPRENOLOL; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DESIPRAMINE; GUANIDINES; KINETICS; MALE; PROPRANOLOL; RATS; RATS, WISTAR; RECEPTORS, SIGMA;

EID: 0030610182     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01051-0     Document Type: Article

References (28)

1. 3H]MK-801 binding to N-methyl -D-aspartate receptors solubilized from rat brain: Effects of glycine site ligands, polyamines, ifenprodil and desipramine. J. Neurochem. 57, 39-45.
2. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
3. Debonnel, G., de Montigny, C., 1996. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disorders. Life Sci. 58, 721-734.
4. Hanner, M., Moebius, F.F., Flandorfer, A., Knaus, H.-G., Striesshig, J., Kempner, E., Glossmann, H., 1996. Purification, molecular cloning and expression of the mammalian sigma1-binding site. Proc. Natl. Acad. Sci. USA 93, 8072-8077.
5. 4 sites in schizophrenic brains. Eur. J. Pharmacol. 314, R3-R5.
6. Hudzik, T.J., De Costa, B.R., McMillan, D.E., 1993. σ Receptor-mediated emetic response in pigeons: Agonists, antagonists and modifiers. Eur. J. Pharmacol. 236, 279-287.
7. 3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Proc. Natl. Acad. Sci. USA 81, 4983-4987.
8. Lowry, O.H., Rothenbrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
9. Malouf, A.T., Swearengen, E., Chavkin, C., 1988. Comparison of the actions phencyclidine and sigma ligands on CA1 hippocampal pyramidal neurons in the rat. Neuropharmacol. 27, 1161-1170.
10. Monnet, F.P., Debonnel, G., Junien, J.L., De Montigny, C., 1990. N-methyl-D-aspartate induced neuronal activation is selectivrely modulated by σ receptors. Eur. J. Pharmacol. 179, 441-445.
11. 3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Mol. Pharmacol. 35, 1-5.
12. 3H]3-PPP binding to sigma receptors. Eur. J. Pharmacol. 184, 203-204.
13. Quirion, R., Bowen, W.D., Itzhak, Y., Junien, J.L., Musacchio, J.M., Rothman, R.B., Su, T.-P., Tam, S.W., Taylor, D.P., 1992. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13, 85-86.
14. Rao, T.S., Cler, J.A., Emmett, M.R., Mick, S., Iyengar, S., Wood, L., 1990. BMY-14802 antagonize harmaline- and D-serine-induced increase in mouse cerebellar cyclic GMP: Neurochemical evidence for a σ receptor-mediated functional modulation of responses mediated by N-methyl-D-aspartate receptor complex in vivo. Mol. Pharmacol. 37, 978-982.
15. Richelson, E., Pfenning, L., 1984. Blockade by antidepressants and related compounds of biogenic amine uptake into rats synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104, 277-286.
16. Reynolds, I.J., Miller, R.J., 1988. Tricyclic antidepressants block N-methyl-D-aspartate receptors: Similarities to the action of zinc. Br. J. Pharmacol. 95, 95-102.
17. Sernagor, E., Kuhn, D., Vyklicky, L. Jr., Mayer, M.L., 1989. Open channel block of NMDA receptor responses evoked by tricyclic antidepressants. Neuron 2, 1221-1227.
18. Shibuya, H., Mori, H., Toru, M., 1992. Sigma receptors in schizophrenic cerebral cortices. Neurochem. Res. 17, 983-990.
19. Shirayama, Y., Nishikawa, T., Umino, A., Takahashi, K., 1993. p-Chlorophenylalanine-reversible reduction of σ binding sites by chronic imipramine treatment in rat brain. Eur. J. Pharmacol. 237, 117-126.
20. Shirayama, Y., Nishikawa, T., Takahashi, K., 1994. Differential effects of repeated DL-pentazocine treatment on sigma binding sites in discrete brain areas of the rat. Neurosci. Lett. 165, 219-222.
21. Su, T.-P., 1991. σ Receptors: Putative links between nervous, endocrine and immune systems. Eur. J. Biochem. 200, 633-642.
22. Tam, S.W., Cook, L., 1984. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)[3H]SKF-10047 and haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. USA 81, 5618-5621.
23. 2 receptor antagonist: Receptor-binding, electrophysiological and neuropharmacological profiles. J. Pharmacol. Exp. Ther. 263, 1167-1174.
24. Tsao, L.-I., Su, T., 1996. IP3 receptor antagonist heparin uncompetitively inhibits [3H](+)-SKF-10047 binding to σ receptors. Eur. J. Pharmacol. 311, R1-R2.
25. Walker, J.M., Bowen, W.D., Walker, P.O., Matsumoto, R.R., De Costa, B., Rice, K.C., 1990. Sigma receptors: Biology and function. Pharmacol. Rev. 42-4, 355-402.
26. 3H]tolyl)guanidine: A selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc. Natl. Acad. Sci. USA 83, 8784-8788.
27. Weissman, A.D., Cassanova, M.F., Kleinman, J.E., London, E.D., De Souza, E.B., 1991. Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia. Biol. Psychiatry 29, 41-54.
28. Yamamoto, H., Yamamoto, T., Sagi, N., Klenerová, V., Goji, K., Kawai, N., Baba, A., Takamori, E., Moroji, T., 1995. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via σ 1 site. J. Neurosci. 15, 731-736.